These results could be interpreted as resulting from unaltered physiological insulin sensitivity and lower lipolysis occurring in adipose tissues, perhaps due to the rapid development of this non-obese NAFLD model. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.